Aurora Cannabis Inc. (ACB) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ACB Revenue Growth
Revenue Breakdown
ACB's revenue distribution by segment and geography
By Geography
ACB Revenue Analysis (2014–2025)
As of May 8, 2026, Aurora Cannabis Inc. (ACB) generated trailing twelve-month (TTM) revenue of $361.1 million, reflecting solid growth of +6.8% year-over-year. The most recent quarter (Q3 2026) recorded $94.2 million in revenue, up 6.8% sequentially.
Looking at the longer-term picture, ACB's 5-year compound annual growth rate (CAGR) stands at +5.0%, indicating steady revenue expansion. The company achieved its highest annual revenue of $343.3 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including CGC (+6.3% YoY), TLRY (+3.0% YoY), and CRON (+64.4% YoY), ACB has underperformed the peer group in terms of revenue growth. Compare ACB vs CGC →
ACB Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ACBCurrent | $361M | +6.8% | +5.0% | 1.4% | |
 CGC | $269M | +6.3% | -7.6% | -43.5% | |
 TLRY | $1.1B | +3.0% | +22.7% | -277.9% | |
 CRON | $193M | +64.4% | +32.9% | -1.5% | |
 OGI | $186M | +68.5% | +16.5% | -34.1% | |
 SMG | $3.4B | -5.9% | -3.7% | 10.5% |
ACB Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $343.3M | +27.0% | $187.6M | 54.6% | $4.9M | 1.4% |
| 2024 | $270.3M | +20.8% | $131.5M | 48.6% | $-46,453,000 | -17.2% |
| 2023 | $223.8M | +1.1% | $14.8M | 6.6% | $-207,193,000 | -92.6% |
| 2022 | $221.3M | -9.8% | $21.2M | 9.6% | $-231,449,000 | -104.6% |
| 2021 | $245.3M | -8.7% | $-21,558,000 | -8.8% | $-282,818,000 | -115.3% |
| 2020 | $268.7M | +9.4% | $-19,935,000 | -7.4% | $-465,782,000 | -173.3% |
| 2019 | $245.5M | +344.8% | $142.4M | 58.0% | $-318,278,000 | -129.6% |
| 2018 | $55.2M | +205.5% | $43.5M | 78.8% | $-95,772,000 | -173.5% |
| 2017 | $18.1M | +1155.5% | $16.1M | 88.9% | $-11,192,000 | -61.9% |
| 2016 | $1.4M | - | $2.2M | 153.0% | $-4,590,000 | -319.0% |
See ACB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ACB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ACB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonACB — Frequently Asked Questions
Quick answers to the most common questions about buying ACB stock.
Is ACB's revenue growth accelerating or slowing?
ACB maintains +6.8% revenue growth, in line with its 5-year CAGR of +5.0%. TTM revenue stands at $361M. Growth rate remains consistent with historical average.
What is ACB's long-term revenue growth rate?
Aurora Cannabis Inc.'s 5-year revenue CAGR of +5.0% reflects the sustained expansion pattern. Current YoY growth of +6.8% is near this long-term average.
How is ACB's revenue distributed by segment?
ACB reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.